NOVA MEASURING INSTRUMENTS ($NVMI) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of $2.18 per share, beating estimates of $2.11 by $0.07. The company also reported revenue of $213,360,000, missing estimates of $214,304,917 by $-944,917.
You can see Quiver Quantitative's $NVMI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NOVA MEASURING INSTRUMENTS Hedge Fund Activity
We have seen 125 institutional investors add shares of NOVA MEASURING INSTRUMENTS stock to their portfolio, and 105 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. removed 900,372 shares (-88.6%) from their portfolio in Q4 2024, for an estimated $177,328,265
- WASATCH ADVISORS LP added 796,629 shares (+49.3%) to their portfolio in Q4 2024, for an estimated $156,896,081
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 521,634 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $102,735,816
- POLAR CAPITAL HOLDINGS PLC added 295,691 shares (+504.5%) to their portfolio in Q4 2024, for an estimated $58,236,342
- FMR LLC removed 234,090 shares (-8.1%) from their portfolio in Q4 2024, for an estimated $46,104,025
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 168,362 shares (-51.4%) from their portfolio in Q4 2024, for an estimated $33,158,895
- LORD, ABBETT & CO. LLC removed 160,071 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $31,525,983
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NOVA MEASURING INSTRUMENTS Analyst Ratings
Wall Street analysts have issued reports on $NVMI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 01/13/2025
To track analyst ratings and price targets for NOVA MEASURING INSTRUMENTS, check out Quiver Quantitative's $NVMI forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
